Amedeo's Top 20

Amedeo Smart

Independent Medical Education

20 June 2014

Multidisciplinary Journal Club

  1. Tsochatzis EA, Bosch J, Burroughs AK.
    Liver cirrhosis.
    Lancet 2014.

  1. .
    High versus low positive end-expiratory pressure during general anaesthesia for open abdominal surgery (PROVHILO trial): a multicentre randomised controlled trial.
    Lancet 2014.

  2. Jacobson IM, Dore GJ, Foster GR, Fried MW, et al.
    Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
    Lancet 2014.

  3. Bennell KL, Egerton T, Martin J, Abbott JH, et al.
    Effect of physical therapy on pain and function in patients with hip osteoarthritis: a randomized clinical trial.
    JAMA 2014;311:1987-97.

  4. Vongpatanasin W.
    Resistant hypertension: a review of diagnosis and management.
    JAMA 2014;311:2216-24.

  1. Manns M, Marcellin P, Poordad F, de Araujo ES, et al.
    Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet 2014.

  2. Pagani O, Regan MM, Walley BA, Fleming GF, et al.
    Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer.
    N Engl J Med 2014.

  3. Weisz DE, More K, McNamara PJ, Shah PS, et al.
    PDA ligation and health outcomes: a meta-analysis.
    Pediatrics 2014;133:e1024-46.

  4. Herz DM, Haagensen BN, Christensen MS, Madsen KH, et al.
    The acute brain response to levodopa heralds dyskinesias in Parkinson disease.
    Ann Neurol 2014.

  5. Ng M, Fleming T, Robinson M, Thomson B, et al.
    Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet 2014.

  1. Al-Khatib SM, Allen LaPointe NM, Chatterjee R, Crowley MJ, et al.
    Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review.
    Ann Intern Med 2014;160:760-73.

  2. Lisnevskaia L, Murphy G, Isenberg D.
    Systemic lupus erythematosus.
    Lancet 2014.

  3. Leitzmann C.
    Vegetarian nutrition: past, present, future.
    Am J Clin Nutr 2014.

  4. Vaz-Luis I, Ottesen RA, Hughes ME, Mamet R, et al.
    Outcomes by Tumor Subtype and Treatment Pattern in Women With Small, Node-Negative Breast Cancer: A Multi-Institutional Study.
    J Clin Oncol 2014.

  5. Kostic AD, Xavier RJ, Gevers D.
    The microbiome in inflammatory bowel disease: current status and the future ahead.
    Gastroenterology 2014;146:1489-99.

  1. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, et al.
    Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people.
    Lancet 2014;383:1899-911.

  2. Smerage JB, Barlow WE, Hortobagyi GN, Winer EP, et al.
    Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500.
    J Clin Oncol 2014.

  3. Langer CJ, Novello S, Park K, Krzakowski M, et al.
    Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol 2014.

  4. Seymour JF, Pfreundschuh M, Trneny M, Sehn LH, et al.
    R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes.
    Haematologica 2014.

  5. Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, et al.
    Efficacy and Safety of Rivaroxaban Compared with Warfarin among Elderly Patients with Nonvalvular Atrial Fibrillation in the ROCKET AF Trial.
    Circulation 2014.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016